Vaccine News
Biological E completes Phase III trials of JE vaccine
City-based drug maker Biological E Limited (BE) has successfully completed Phase II and III study of inactivated Japanese Encephalitis (JE) vaccine on healthy infants of 1 to 3 years old across eight sites in India.
“This is an important milestone in the clinical development of this vero cell based inactivated JE vaccine manufactured in India based on the technology transfer agreement with Intercell,”
|
|
